₹ 3.7 Cr
Volume Transacted
(Dec 20, 2024)
17.4 K
Stocks Traded
(Dec 20, 2024)
Last Updated on: Dec 22, 2024
Lupin Ltd
NSE: LUPIN
EPS
₹ 57.57
Last updated on: Dec 20, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Lupin Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 97,970 Cr
EPS
₹ 57.6
P/E Ratio (TTM) *
37.3
P/B Ratio (TTM) *
6.3
Day’s High *
2176.0
Day’s Low
₹ 2137.95
DTE *
0.2
ROE *
16.8
52 Week High
₹ 2312.0
52 Week Low
₹ 1200.35
ROCE *
18.3
* All values are consolidated
Last Updated time: 22 Dec 9.00 AM
* All values are consolidated
Last Updated time: 22 Dec 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
20 Dec 2024 | 2147.55 | 2160.5 | 2176 | 2137.95 |
19 Dec 2024 | 2162.2 | 2098.05 | 2166.2 | 2080.1 |
18 Dec 2024 | 2098.7 | 2069.95 | 2112 | 2040 |
17 Dec 2024 | 2045.9 | 2064.7 | 2076.65 | 2041.55 |
16 Dec 2024 | 2062.4 | 2095.45 | 2095.45 | 2059 |
13 Dec 2024 | 2075.55 | 2117.1 | 2117.1 | 2040.25 |
12 Dec 2024 | 2117.1 | 2151 | 2158 | 2109 |
11 Dec 2024 | 2149.4 | 2136 | 2161 | 2131.55 |
10 Dec 2024 | 2134.45 | 2106.8 | 2144 | 2106.8 |
09 Dec 2024 | 2106.65 | 2133.55 | 2139 | 2098.1 |
Date | Price (₹) |
---|---|
20 Dec 2024 | 2147.55 |
19 Dec 2024 | 2162.2 |
18 Dec 2024 | 2098.7 |
17 Dec 2024 | 2045.9 |
16 Dec 2024 | 2062.4 |
13 Dec 2024 | 2075.55 |
12 Dec 2024 | 2117.1 |
11 Dec 2024 | 2149.4 |
10 Dec 2024 | 2134.45 |
09 Dec 2024 | 2106.65 |
Strength
3
S
Weakness
2
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 97,971
Asset Value
₹ 12,903
6.6 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Lupin Ltd | 57 | 97,970 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,33,920 |
Divis Laboratories Ltd | 69 | 1,55,160 |
Cipla Ltd | 57 | 1,18,917 |
Torrent Pharmaceuticals Ltd | 51 | 1,16,225 |
Mankind Pharma Ltd | 52 | 1,12,324 |
Historical Market Cap of Lupin Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Lupin Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Lupin Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Lupin Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Lupin receives USFDA nod for new HIV drug
Emtricitabine and tenofovir alafenamide combination is used together with other medicines ...
19 Dec 2024 09:54
Lupin allots 36,979 equity shares under ESOP
Lupin has allotted 36979 fully paid-up equity shares of Rs 2/- each. These shares have bee...
19 Dec 2024 16:25
Lupin acquires 3 anti-diabetic drugs from Boehringer Ingelheim
GIBTULIO (empagliflozin), GIBTULIO MET (empagliflozin + metformin) and AJADUO (empaglifloz...
14 Dec 2024 10:33
Lupin acquires 3 anti-diabetes trademarks from Boehringer Ingelheim
Lupin announced today the acquisition of anti-diabetes trademarks GIBTULIO', GIBTULIO MET'...
13 Dec 2024 18:19
Lupin Ltd gains for fifth session
Lupin Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2111.45,...
25 Nov 2024 13:00
Lupin allots 2642 equity shares under ESOP
Lupin allots 2642 equity shares under ESOP on 19 November 2024. In view of the above, the ...
19 Nov 2024 14:28
Concalls
Unlimited trading starting at just Rs. 249*